United Therapeutics pays $3m to exclusively license CollPlant’s bio-inks for 3D printing kidneys 

Biotechnology firm United Therapeutics and Israeli bioprinting firm CollPlant have broadened their partnership to enter into the serial manufacturing of 3D printed kidneys.  The new agreement, which builds on the companies’ initial deal in 2018, will combine CollPlant’s novel technologies with United Therapeutics’ manufacturing capacity to put 3D printed organs into production. As part of the […]

from 3D Printing Industry https://bit.ly/2RQ7kzy